Researchers from the UK’s University of Nottingham revealed that an experimental cancer drug showed promising lab results against viral infections, and specifically against COVID-19.(1) News about how to control or combat the SARS-CoV-2 virus has overtaken media outlets and public debate, to the detriment of addressing other public health issues. For example, during 2020 the rates of suicides,(2) especially among young people, and drug overdoses(3) have risen dramatically. Recently,  one focus of media reports has been debunking potential treatments that aren’t developed or manufactured by the pharmaceutical industry while encouraging the public to keep their eye squarely on the COVID-19 vaccine. News stories abound about where to get the vaccine, when and where the drug is being shipped, and assurances that the side effects are minimal. Recent research published in the journal Viruses,(4) however, revealed the drug thapsigargin may have broad-spectrum antiviral activity, including against coronaviruses such as SARS-CoV-2. Experimental …